Agenda

By the end of the congress, participants will be able to:

  • Discuss the results and practical implications of the latest clinical trials for the management of patients with type 1 and type 2 diabetes
  • Apply lifestyle and pharmacological approaches to the prevention and treatment of diabetes complications
  • Explain the latest guidelines and their implications for clinical practice
  • Describe the role of evidence-based medicine and how it applies to health care decision making
DAY 1: FRIDAY, APRIL 29
All times are set to Eastern Time
PLEASE NOTE: All sessions are IN PERSON and VIRTUAL, unless noted otherwise
9:00 am Accredited Symposium: The Role Of Dual GIP/GLP-1 Receptor Agonism in Type 2 Diabetes
PLENARY SESSION #1
10:00 am Welcome and Introductions Zaina Albalawi, MD; Alanna Weisman, MD
10:10 am Diabetes and Heart Failure: What must a diabetologist know? Shelley Zieroth, MD
10:30 am Obesity and Diabetes Sean Wharton, MD
10:50 am Decolonizing Diabetes Health Care Randal Bell
11:10 am Panel Discussion and Q & A Shelley Zieroth, MD; Sean Wharton, MD;
Randal Bell
 
11:35 am IN PERSON: Health Break  
12:00 pm Accredited Symposium: Does My Patient With Shortness of Breath Have HfpEF?
PLENARY SESSION #2
1:05 pm Update on Incretin Therapies Alice Y.Y. Cheng, MD
1:25 pm Nutrition and Diabetes Michael Mindrum, MD
1:45 pm Panel discussion and Q & A Alice Y.Y. Cheng, MD;
Michael Mindrum, MD
 
2:05 pm IN PERSON: Health Break  
PLENARY SESSION #3
2:30 pm Diabetes and Mental Health Barry Simon, MD
2:50 pm Diabetes and Chronic Kidney Disease David Cherney, MD
3:10 pm Panel Discussion and Q & A Barry Simon, MD; David Cherney, MD
 
3:30 pm Accredited Symposium: Data Overload: Making Use of Continuous Glucose Data in Practice and Research
4:30 pm IN PERSON EXCLUSIVE Keynote Presentation: Digital Models of Diabetes Care Athena Phillis-Tsimikas, MD
4:50 pm IN PERSON EXCLUSIVE Reception and Networking Event with Live Jazz Band
6:00 pm End of Day 1


DAY 2: SATURDAY, APRIL 30
All times are set to Eastern Time
PLEASE NOTE: All sessions are IN PERSON and VIRTUAL, unless noted otherwise
9:00 am Accredited Symposium: A Multidisciplinary Perspective on the Role of GLP-1RAs in Diabetes
PLENARY SESSION #4
10:00 am Welcome and Introductions Zaina Albalawi, MD; Alanna Weisman, MD
10:10 am Fatty Liver Disease and NASH Giada Sebastiani, MD
10:30 am Technology Update Alanna Weisman, MD
10:50 am Exercise and Type 1 Diabetes Jane Yardley, PhD
11:10 am Panel discussion and Q & A Giada Sebastiani, MD; Alanna Weisman, MD;
Jane Yardley, PhD
 
11:35 am IN PERSON: Health Break  
12:00 pm Accredited Symposium: Obesity Management in your Practice: Simple Recommendations to Improve Patient Care
PLENARY SESSION #5
1:05 pm Update on Dyslipidemia George Thanassoulis, MD
1:25 pm Remission in Type 2 Diabetes Zubin Punthakee, MD
1:45 pm Panel Discussion and Q & A George Thanassoulis, MD
Zubin Punthakee, MD
 
2:05 pm IN PERSON: Health Break  
PLENARY SESSION #6
2:30 pm Current and Future Approaches to Type 1 Diabetes: Beyond Insulin and Technology Peter Senior, MD
2:50 pm Debate: Use of SGLT2is in Hospital Jacob A. Udell, MD; Shelley Zieroth, MD
3:30 pm Panel Discussion and Q & A Peter Senior, MD; Jacob A. Udell, MD;
Shelley Zieroth, MD
 
3:50 pm Closing Remarks Zaina Albalawi, MD; Alanna Weisman, MD
4:00 pm Congress End